198 related articles for article (PubMed ID: 24767719)
1. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial.
Webb NJ; Frew E; Brettell EA; Milford DV; Bockenhauer D; Saleem MA; Christian M; Hall AS; Koziell A; Maxwell H; Hegde S; Finlay ER; Gilbert RD; Booth J; Jones C; McKeever K; Cook W; Ives NJ;
Trials; 2014 Apr; 15():147. PubMed ID: 24767719
[TBL] [Abstract][Full Text] [Related]
2. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
Webb NJ; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Wheatley K; Ives NJ
Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
[TBL] [Abstract][Full Text] [Related]
3. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
Christian MT; Webb NJ; Woolley RL; Afentou N; Mehta S; Frew E; Brettell EA; Khan AR; Milford DV; Bockenhauer D; Saleem MA; Hall AS; Koziell A; Maxwell H; Hegde S; Finlay ER; Gilbert RD; Jones C; McKeever K; Cook W; Ives N
Health Technol Assess; 2022 Jan; 26(3):1-94. PubMed ID: 35060851
[TBL] [Abstract][Full Text] [Related]
4. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Deeks JJ; Wheatley K; Ives NJ;
BMJ; 2019 May; 365():l1800. PubMed ID: 31335316
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.
Christian MT; Webb NJA; Mehta S; Woolley RL; Afentou N; Frew E; Brettell EA; Khan AR; Milford DV; Bockenhauer D; Saleem MA; Hall AS; Koziell A; Maxwell H; Hegde S; Prajapati H; Gilbert RD; Jones C; McKeever K; Cook W; Ives N
JAMA Pediatr; 2022 Mar; 176(3):236-243. PubMed ID: 34928294
[TBL] [Abstract][Full Text] [Related]
6. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
Abeyagunawardena AS; Thalgahagoda RS; Dissanayake PV; Abeyagunawardena S; Illangasekera YA; Karunadasa UI; Trompeter RS
Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
[TBL] [Abstract][Full Text] [Related]
7. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial.
Abeyagunawardena AS; Trompeter RS
Arch Dis Child; 2008 Mar; 93(3):226-8. PubMed ID: 17573408
[TBL] [Abstract][Full Text] [Related]
8. REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study- protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study.
Schijvens AM; Dorresteijn EM; Roeleveld N; Ter Heine R; van Wijk JAE; Bouts AHM; Keijzer-Veen MG; van de Kar NCAJ; van den Heuvel LPWJ; Schreuder MF
BMJ Open; 2017 Sep; 7(9):e018148. PubMed ID: 28963315
[TBL] [Abstract][Full Text] [Related]
9. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T; Nakanishi K; Ishikura K; Ito S; Nakamura H; Sako M; Saito-Oba M; Nozu K; Shima Y; Iijima K; Yoshikawa N;
BMC Nephrol; 2018 Sep; 19(1):223. PubMed ID: 30200895
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M; Sinha A; Khandelwal P; Hari P; Bagga A
Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
[TBL] [Abstract][Full Text] [Related]
11. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
Raja K; Parikh A; Webb H; Hothi D
Pediatr Nephrol; 2017 Jan; 32(1):99-105. PubMed ID: 27677978
[TBL] [Abstract][Full Text] [Related]
12. Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial.
Gulati A; Sinha A; Sreenivas V; Math A; Hari P; Bagga A
Clin J Am Soc Nephrol; 2011 Jan; 6(1):63-9. PubMed ID: 20847092
[TBL] [Abstract][Full Text] [Related]
13. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
Larkins N; Kim S; Craig J; Hodson E
Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
[TBL] [Abstract][Full Text] [Related]
14. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
[TBL] [Abstract][Full Text] [Related]
15. Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
Veltkamp F; Khan DH; Reefman C; Veissi S; van Oers HA; Levtchenko E; Mathôt RAA; Florquin S; van Wijk JAE; Schreuder MF; Haverman L; Bouts AHM
BMJ Open; 2019 Aug; 9(8):e027011. PubMed ID: 31375606
[TBL] [Abstract][Full Text] [Related]
16. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
Kainth D; Hari P; Sinha A; Pandey S; Bagga A
Clin J Am Soc Nephrol; 2021 Feb; 16(2):225-232. PubMed ID: 33478976
[TBL] [Abstract][Full Text] [Related]
17. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
Sinha A; Saha A; Kumar M; Sharma S; Afzal K; Mehta A; Kalaivani M; Hari P; Bagga A
Kidney Int; 2015 Jan; 87(1):217-24. PubMed ID: 25029428
[TBL] [Abstract][Full Text] [Related]
18. Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial.
Sheikh S; Mishra K; Kumar M
Pediatr Nephrol; 2021 Oct; 36(10):3143-3150. PubMed ID: 33861375
[TBL] [Abstract][Full Text] [Related]
19. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM; Knight JF; Willis NS; Craig JC
Cochrane Database Syst Rev; 2003; (1):CD001533. PubMed ID: 12535410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
